Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOLUTEGRAVIR vs DONANEMAB-AZBT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOLUTEGRAVIR vs DONANEMAB-AZBT: Safety Overview

Metric DOLUTEGRAVIR DONANEMAB-AZBT
Total FAERS Reports 10,772 1,018
Deaths Reported 1,001 18
Death Rate 9.3% 1.8%
Hospitalizations 2,225 117
Average Patient Age 44.5 yrs 74.6 yrs
% Female Patients 42.1% 58.6%
FDA Approval Date Aug 12, 2013 N/A
Manufacturer ViiV Healthcare Company N/A
Route ORAL N/A
Marketing Status Prescription Prescription